Similar articles

• [Oral contraceptives: cardiovascular complications and additional risk factors (author's transl)].

  Herzog C. Herzog C. Schweiz Rundsch Med Prax. 1979 Oct 9;68(41):1321-9. Schweiz Rundsch Med Prax. 1979. PMID: 394143 Review. German. No abstract available.
• Oral contraceptives and nonfatal vascular disease.

  Porter JB, Hunter JR, Jick H, Stergachis A. Porter JB, et al. Obstet Gynecol. 1985 Jul;66(1):1-4. Obstet Gynecol. 1985. PMID: 4011060
• [Contraceptive agents and cardiovascular diseases].

  Lisin N, Lambotte R, Remacle P. Lisin N, et al. Brux Med. 1977 Nov;57(11):499-502. Brux Med. 1977. PMID: 922541 French. No abstract available.
• The risks of oral contraception.

  McEwan J. McEwan J. Br J Hosp Med. 1979 Feb;21(2):144, 146, 148-50. Br J Hosp Med. 1979. PMID: 465849 No abstract available.
• [The pill and thromboembolism. 1. Thrombogenesis and additional risk factors. A review of the literature].

  Herzog C, Mall-Haefeli M. Herzog C, et al. Ther Ggw. 1979 Oct;118(10):1550-74. Ther Ggw. 1979. PMID: 386549 Review. German. No abstract available.